Evidence map›Paper›PMID 30190558›Full record

Trial reportScientific reports2018

The emerging sub-genotype C2 of CoxsackievirusA10 Associated with Hand, Foot and Mouth Disease extensively circulating in mainland of China.

Tianjiao Ji, Yue Guo, Wei Huang, Yong Shi, Yi Xu, Wenbin Tong, Wenqing Yao, Zhaolin Tan, Hanri Zeng, Jiangtao Ma and 8 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Tianjiao JiMinistry of Health Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Yue GuoMinistry of Health Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Wei HuangHunan Center for Disease Control and Prevention, Changsha, Hunan Province, People's Republic of China.
Yong ShiJiangxi Center for Disease Control and Prevention, Nanchang, Jiangxi Province, People's Republic of China.
Yi XuShaanxi Center for Disease Control and Prevention, Xi'an, Shaanxi Province, People's Republic of China.
Wenbin TongSichuan Center for Disease Control and Prevention, Chengdu, Sichuan Province, People's Republic of China.
Wenqing YaoLiaoning Center for Disease Control and Prevention, Shenyang, Liaoning Province, People's Republic of China.
Zhaolin TanTianjin municipal Center for Disease Control and Prevention, Tianjin municipal, People's Republic of China.
Hanri ZengGuangdong Center for Disease Control and Prevention, Guangzhou, Guangdong Province, People's Republic of China.
Jiangtao MaNingxia Center for Disease Control and Prevention, Yinchuan, Ningxia Province, People's Republic of China.
Hua ZhaoChongqing Center for Disease Control and Prevention, Chongqing municipal, People's Republic of China.
Taoli HanMinistry of Health Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Yong ZhangMinistry of Health Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.ORCID 0000-0002-2692-5437
Dongmei YanMinistry of Health Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Qian YangMinistry of Health Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Shuangli ZhuMinistry of Health Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Yan ZhangMinistry of Health Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. zhangyan9876543@163.com.
Wenbo XuMinistry of Health Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. wenbo_xu1@aliyun.com.
National Institute for Viral Disease Control and Prevention · CNHunan Provincial Center for Disease Control and Prevention · CNNanchang Center for Disease Control and Prevention · CNNingxia Center for Diseases Prevention and Control · CNShenyang Center for Disease Control and Prevention · CNSichuan Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coxsackievirus A10 (CV-A10) associated with Hand, foot, and mouth disease (HFMD) cases emerged increasingly in recent years. In this study, the samples from nation-wide HFMD surveillance, including 27 out of 31 provinces in China were investigated, and the continuous and extensive virological surveillance, covered 13 years, were conducted to provide a comprehensive molecular characterization analysis of CV-A10. 855 CV-A10 viruses (33 severe cases included), were isolated from HFMD children patients during 2009 to 2016 in China. 164 representative sequences from these viruses, together with 117 CV-A10 sequences downloaded from GenBank based on entire VP1 were recruited in this study. Two new genotypes (F and G) and two sub-genotypes (C1 and C2) were identified. Among 264 Chinese sequences, 9 of them were genotype B, 8 of them were C1, and the other (247) were C2, the predominant sub-genotype in China since 2012. Chinese C2 viruses showed obvious temporal characteristics and can be divided into 3 clusters (cluster 1~3). Cluster 3 viruses was circulating extensively during 2014 and 2016 with more severe cases. It is very necessary and important to continuously conduct the extensive virological surveillance for CV-A10, and further evolutionary studies will provide more evidence on its evolution and virulence.

Indexed as

Evolution, MolecularGenotypeAdolescentChildChild, PreschoolChinaEnterovirus C, HumanFemaleHand, Foot and Mouth DiseaseHumansMale

Identifiers

PMID30190558
PMCPMC6127217
OpenAlexW2889448959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.